Mylan's EpiPen goes generic, Herbalife saga far from over, Caesars tanks on lawsuit ruling

Here are some of the stocks the Yahoo Finance team will be watching for you today.

Caesars Entertainment (CZR) plunged following news late Friday that a judge refused to protect the parent company of bankrupt Caesars Entertainment Operating Company from multibillion-dollar bondholder lawsuits. The company plans to appeal the ruling.

Symantec (SYMC) shares were up in early trading after Barron’s reported over the weekend that shares of the software security firm could rise 25% or more over the next two years. Barron’s said cost cuts, the acquisition of Blue Coat Systems and new management could help propel the stock price.

Mylan (MYL) continues to grab headlines, following the company’s announcement this morning that it will sell a generic version of its EpiPen injector at half the price of the branded product. The move to sell a two-pack for $300 comes after widespread outrage over the 500% increase in the allergy treatment’s price over eight years.

Herbalife (HLF) shares were higher in early trading following news after the bell Friday that Carl Icahn raised his stake in the nutritional supplements company. Icahn bought another 2.3 million shares, boosting his stake to 21%. That came after fellow billionaire Bill Ackman told CNBC he was approached to buy some of Icahn’s stake in the company — whose stock Ackman is shorting. Icahn criticized Ackman for what he called Ackman’s “obsession” with Herbalife.